tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Reata Pharmaceuticals's activity chart (see below) currently has 141 price targets and 114 ratings on display.
Analysts average stock forecasts to be materialized ratio is 57.86% with an average time for these price targets to be met of 215.11 days.
Most recent stock forecast was given by from CANTOR FITZGERALD on 15-Aug-2023. First documented stock forecast 20-Jun-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Aug-2023
$172
$-0.36 (-0.21%)
$145
3 years 27 days ago
(15-Aug-2023)
7/13 (53.85%)
$2.87 (1.70%)
152
Buy Since 26-Apr-2021
$172
$-0.36 (-0.21%)
$110
3 years 1 months 10 days ago
(01-Aug-2023)
6/6 (100%)
$5.9 (3.55%)
222
Buy Since 06-Jul-2023
$172.5
$0.14 (0.08%)
$172.5
3 years 1 months 10 days ago
(01-Aug-2023)
1/3 (33.33%)
$6.4 (3.85%)
22
Buy Since 20-Jun-2016
$172.5
$0.14 (0.08%)
3 years 1 months 10 days ago
(01-Aug-2023)
14/22 (63.64%)
$6.4 (3.85%)
270
Hold Since 09-Aug-2022
$173
$0.64 (0.37%)
3 years 1 months 11 days ago
(31-Jul-2023)
4/8 (50%)
$7.42 (4.48%)
335
What is RETA (Reata Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on RETA (Reata Pharmaceuticals)?
Which analyst has the most public recommendations on RETA (Reata Pharmaceuticals)?
Which analyst is the currently most bullish on RETA (Reata Pharmaceuticals)?
Which analyst is the currently most reserved on RETA (Reata Pharmaceuticals)?
